Sagent Pharmaceuticals Announces FDA Approval Of Midazolam Injection, USP

Links shared publicly online about this topic.

  • 682
    total visits

Sagent Pharmaceuticals Announces FDA Approval Of Midazolam Injection, USP

medicalnewstoday.com

Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, announced U.S. FDA's approval of four presentations of midazolam injection, USP, a general anesthetic. Sagent expe

View full resource at medicalnewstoday.com

Tags: Pain, Pharma, FDA

  • Share

Most Recently Shared on December 3, 2010 at 8:05 pm By:

mnt_pharma MNT Pharma News

Sagent Pharmaceuticals Announces FDA Approval Of Midazolam Injection, USP http://mnt.to/3Nx9 #pharma #pharmaceutical

1 year ago...

Also Shared By:

medical_tweets medical_tweets

MNT Pain News MNT Pain News

MNT Drug Approvals MNT Drug Approvals

Sagent Pharmaceuticals Announces FDA Approval Of Bacitracin For Injection, USP

medicalnewstoday.com — “Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, announced FDA approval of bacitracin for injection, USP (bacitracin), an anti-infective product used to treat pneumView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 15, 2010 at 3:56 pm By:

Lung_Breathing Lungs and Breathing OW Health

Sagent Pharmaceuticals Announces FDA Approval Of Bacitracin For Injection, USP: Sagent Pharmaceuticals, Inc., a pr... http://bit.ly/bxy17L

2 years ago...

FDA approves Sagent's bacitracin for pneumonia and empyema

news-medical.net — “Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced FDA approval of bacitracin for injection, USP (bacitracin), an anti-infective product used to treat pneumonia and empyema. Bacitracin will be offered in a 50,000 MU, AP-rated, preservative-free, latex-free, single-dose vial packaged both individually and in packages of ten.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 13, 2010 at 4:46 am By:

NewsMedical News-Medical.Net Health News

FDA approves Sagent's bacitracin for pneumonia and empyema: Sagent Pharmaceuticals, Inc., a privately held special... http://bit.ly/b1TeIw

2 years ago...

Sagent Pharmaceuticals Announces FDA Approval Of Labetalol Hydrochloride Injection, USP

medicalnewstoday.com — “Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to contrView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on February 9, 2010 at 6:15 pm By:

mnt_clinical MNT Clinical Trials Health News

Sagent Pharmaceuticals Announces FDA Approval Of Labetalol Hydrochloride Injection, USP http://mnt.to/3xnF #clinicaltrials

2 years ago...

Advertisement